| Name: | Bosutinib Dimer Impurity |
| Catalogue No. | VE006041 |
| CAS No. | N/A |
| Molecular Formula | C47H46Cl4N8O6 |
| Molecular Weight | 960.7 |
| Status | In-Stock |
| IUPAC Name | 4-((3-((3-cyano-4-((2,4-dichloro-5-methoxyphenyl)amino)-6- methoxyquinolin-7-yl)oxy)propyl)(2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3- (4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile |
| Description | Bosutinib Dimer Impurity ( CAS No: N/A ) or 4-((3-((3-cyano-4-((2,4-dichloro-5-methoxyphenyl)amino)-6- methoxyquinolin-7-yl)oxy)propyl)(2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3- (4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile is associate impurity of Bosutinib. Bosutinib is employed to treat chronic myeloid leukemia that has an abnormal chromosome called the Philadelphia chromosome. |
| References | “Sci-Hub | Global Target Profile of the Kinase Inhibitor Bosutinib in Primary Chronic Myeloid Leukemia Cells | 10.1038/Leu.2008.334.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1038/leu.2008.334. |
